Y&R wins Merck brands in Indonesia

Y&R has won two accounts for drugs giant Merck in Indonesia.

The announcement:

JAKARTA, 4 April 2014– Y&R Group Indonesia has won two significant accounts, pan-regional creative and strategic consultancy, for multinational pharmaceutical giant Merck.

Y&R has just been awarded the regional creative duties for Merck’s neurotropic vitamin Neurobion. This concluded a four-agency pitch, followed by strategy and testing across key target markets Indonesia, India and the Philippines.

Prior to that, Y&R was appointed to handle strategy consultancy for Merck’s iron supplement Sangobion.

“I am very pleased with our co-operation with Y&R Indonesia. Not only has the team managed to come up with a strong creative idea that works across our regional markets in Asia, but the strategic thinking behind the brands are also strong. I am also thankful that I get a highly dedicated professional team. The energy and commitment we receive from the team is marvellous. This is a very important new campaign for us, not only for Indonesia, but also for the region, as we are transforming Neurobion from a fully prescription driven product to an over the counter product. I do wish this new regional campaign will translate into flying sales performance. The same high expectation goes for the Sangobion strategy consultancy as the output will be used for creating a strong foundation for the upcoming new product under our core brand – Sangobion,” said Feni Herawati, Head of Marketing, Consumer Health – Pharmaceuticals Division.

Commenting on the win, Y&R Group Indonesia CEO John Domas said, “Two more great wins for Y&R Indonesia as momentum continues in 2014. Being recognised for both our creative and strategic strength by a major multinational like Merck is testament to our agency capabilities across Y&R Advertising, The Campaign Palace and VML Qais Indonesia.”

Source: press release


Get the latest media and marketing industry news (and views) direct to your inbox.

Sign up to the free Mumbrella Asia newsletter now.



Sign up to our free daily update to get the latest in media and marketing